Clinical trials
Cardiovascular clinical trials
Below are recruiting cardiovascular clinical trials, each written for real people, not researchers. We’re tracking 1,172 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07547098Recruiting
Heart, Kidney, and Metabolism Health Long-Term Study
This research study tracks patients with heart disease, kidney disease, or metabolic conditions (like diabetes) over time to understand how these conditions connect and affect long-term health. By collecting medical records and health information, researchers aim to predict outcomes and improve care.
Fuzhou, FujianAges 18–80 - NCT07551492RecruitingPhase 3
Testing HRS9531 for heart and blood vessel disease
This study tests whether a new drug called HRS9531 can help people with atherosclerotic cardiovascular disease (hardened arteries affecting the heart and blood vessels). The trial will check if it's safe and effective for managing this condition.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07557108Recruiting
Nerve Blocks to Improve Recovery After Heart Surgery
This study tests whether special numbing injections around nerves in the chest wall (fascial plane blocks) help patients recover better and have less pain after open-heart surgery. The goal is to see if this technique improves how you feel and function in the days after your operation.
Ordu, AltinorduAges 18–70 - NCT07588256Recruiting
AI Digital Health Platform for High Blood Pressure and Related Conditions
This study uses artificial intelligence and a digital health app to help manage high blood pressure, high cholesterol, diabetes, kidney disease, and heart disease. It aims to help people track their health at home and receive better care recommendations through technology.
New Taipei CityAges Any age - NCT07617844Recruiting
Advanced MRI imaging for heart disease diagnosis
This study uses advanced magnetic resonance imaging (MRI) scans to better understand and diagnose heart disease. If you have suspected or confirmed heart problems, this trial may help doctors get clearer pictures of your heart muscle and tissue to figure out what's causing your symptoms.
Hangzhou, ZhejiangAges 18 years+ - NCT07656727RecruitingPhase 2
A study of BGE-102 for obesity and heart risk
This trial tests an experimental drug called BGE-102 in people with obesity and signs of inflammation. It aims to see if the drug can help reduce body weight and improve heart health. Participants must be willing to keep a stable diet and exercise routine.
Chandler, ArizonaAges 18 years+ - NCT07572721Enrolling by invitation
Virtual Fitness and Health Program for Heart Health
This study tests a virtual fitness program delivered through Peloton and wearable fitness trackers to help adults improve their heart health and fitness. You'll exercise from home, track your progress with a device you already own, and provide blood samples to measure your health improvements.
San Francisco, CaliforniaAges 30–60 - NCT07316075Enrolling by invitation
Heart and metabolic health in silent pheochromocytoma or paraganglioma
This study looks at heart and metabolic health in people who have pheochromocytomas or paragangliomas that do not produce extra hormones. It aims to understand whether these 'silent' tumors affect cardiovascular and metabolic health, and how they compare to other cases.
AthensAges 18 years+ - NCT07207603Enrolling by invitation
Cardiovascular risk study in Milano-Bicocca area
This study looks at heart disease risk factors in people living near the University of Milano-Bicocca. It helps researchers understand how common these risks are in the local community.
MilanAges 25 years+ - NCT07136675Enrolling by invitation
Healthy Heart & Blood Markers in Chinese Adults
This study aims to create a reference library of healthy hearts and blood markers for Chinese adults. If you qualify, you will help doctors better understand what's normal for people like you.
Beijing, Beijing MunicipalityAges 20–80 - NCT06992284Enrolling by invitation
Heart disease study in Niigata
This study looks at the long-term outlook for people with heart disease in Niigata, Japan. It helps doctors learn more about what affects recovery and health over time.
Niigata, NiigataAges 18 years+ - NCT06959784Enrolling by invitationPhase 4
A study on new diabetes drugs for heart health and remission
This trial tests if newer diabetes medications can reduce heart risk and help achieve diabetes remission in people newly diagnosed with type 2 diabetes. It may be an option if you have not taken diabetes drugs before or stopped them over three months ago, and your blood sugar and weight are in certain ranges.
BeijingAges 30–70 - NCT06951451Enrolling by invitation
Smartphone app to improve heart medication use in Oman
This study tests whether a smartphone app called MED-AD helps people in Oman with heart conditions take their medications more regularly. If you join, you'll use the app and the researchers will compare your medication habits to those who don't use it.
MuscatAges 18 years+ - NCT06908473Enrolling by invitationPhase 3
Tongmai Jiangtang capsule for heart risks in metabolic syndrome
This trial tests whether the Tongmai Jiangtang capsule can reduce serious heart and stroke problems in older adults with metabolic syndrome who are also at high risk for heart disease. It focuses on people with a specific traditional Chinese medicine pattern called Qi-deficiency and Blood Stasis.
Guangzhou, GuangdongAges 65 years+ - NCT06763549Enrolling by invitation
AI-powered wearable patch for heart and lung monitoring
This study tests an AI-powered wearable patch (the COR ECG) to see if it can better track heart and lung health. It may help doctors find problems earlier without needing bulky equipment.
Melbourne, FloridaAges 18 years+ - NCT06697418Enrolling by invitation
Physical activity and heart health in peritoneal dialysis patients
This study uses a wrist-worn device to see how daily physical activity affects heart health and other outcomes for people on peritoneal dialysis. If you are on PD, can walk on your own, and are willing to wear a tracker, you may be able to join.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06652776Enrolling by invitation
Italian COPD patient registry study
This study is creating a registry to better understand Chronic Obstructive Pulmonary Disease (COPD) in Italian patients. It will collect information from people with COPD to improve care and research.
Milan, MilanAges 40 years+ - NCT06641843Enrolling by invitation
Heart stress test using MRI for children with heart disease
This study uses magnetic resonance imaging (MRI) to look at blood flow to the heart muscle during stress in children with certain heart conditions. It may help doctors better understand how the heart is working.
Chengdu, SichuanAges Up to 18 years - NCT06602934Recruiting
Pneumonia, heart health, and your body's germs
This study looks at how pneumonia affects the long-term health of your heart and lungs by studying the germs that live in your body. It may help doctors understand why some people get worse and how to better protect your heart after a serious infection.
AngersAges 18–80 - NCT06593704Enrolling by invitation
Heart health program for primary care patients
This trial tests a program to help people manage their heart disease risk through their primary care practice. If you are 40 to 90 years old and already in a care program for heart disease, high risk, or diabetes, this might be for you.
The Hague, South HollandAges 40–90 - NCT06576544Enrolling by invitation
Wearables to Track Postpartum Blood Pressure
This study uses wearable devices to track your blood pressure after childbirth. The goal is to learn when blood pressure problems occur and help create better monitoring guidelines so you and future parents can get the right care at the right time.
La Jolla, CaliforniaAges 18–50 - NCT06471140Enrolling by invitation
Heart Health in Pregnancy After Frozen Embryo Transfer
This study looks at how the heart and blood vessels adjust during pregnancy in women who became pregnant after a frozen embryo transfer (FET) using IVF. It aims to understand if different types of FET cycles affect maternal health, and may help improve future fertility care.
AalborgAges 18–40 - NCT06112327Enrolling by invitation
Long-term follow-up for a gene editing heart therapy
This study follows people who already received an experimental gene editing treatment for cardiovascular disease in a prior Verve trial. The goal is to monitor their health and any long-term effects over time.
AucklandAges 18 years+ - NCT05971433Enrolling by invitation
Studying how body stress signals affect sleep and heart health
This study looks at how “stress signals” in the body after an injury may affect sleep and cardiovascular (heart and blood vessel) health. It may help researchers understand what contributes to recovery and how to improve outcomes for wounded service members.
Bethesda, MarylandAges 18 years+
Hear when a new Cardiovascular trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cardiovascular?
- Yes. Clin2 currently lists 1,172 recruiting cardiovascular studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cardiovascular trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cardiovascular trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.